Fulcrum Therapeutics, Inc.
FULC
Revenue
0.00
0.000.00%
-Assets
294.26M
▲61.67M▲26.51%
3 Months ChangeLiabilities
20.47M
▲1.47M▲7.74%
3 Months ChangeFree Cash Flow
-25.31M
▼-1.03M▼-4.22%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-24
Form 8-K
ID: 0000950170-24-109069
2024-09-12
Form 8-K
ID: 0001193125-24-217822
2024-08-22
Form 8-K
ID: 0001193125-24-205347
2024-07-31
Form 10-Q
ID: 0000950170-24-088238
2024-07-31
Form 8-K
ID: 0000950170-24-088236
2024-06-17
Form 8-K
ID: 0001193125-24-162653
2024-05-13
Form 10-Q
ID: 0000950170-24-058193
2024-05-13
Form 8-K
ID: 0000950170-24-058187
2024-02-27
Form 8-K
ID: 0000950170-24-020615
2023-11-07
Form 10-Q
ID: 0000950170-23-059755